Status:
Topic selection
Technology type:
Medicine
Decision:
Not selected
Reason for decision:
Not eligible for Health Technology Evaluation guidance
Further information:
Decision makers have concluded that this technology will not progress as a potential technology appraisal (TA) or a highly specialised technology (HST) as is not a new active substance and already a racemic mixture of the same active substance (Zopiclone) already being used therefore, there would be no value in a TA.
ID number:
12020

Project Team

Project lead
Danielle Lees

Email enquiries

If you have any queries please email [email protected]

Timeline

Key events during the development of the guidance:

Date Update
11 July 2024 Topic selection

For further information on how we select topics for development, please see our page about prioritising our guidance topics